Utilizing serum samples from both EPICC enrollees and enrollees from a another protocol (COVID-19 Antibody Prevalence in Military Personnel Deployed to New York (CAMP-NYC)), we assessed the sensitivity of the MMIA to detect IgG and IgM seroconversion. This evidence concerns the gene CD40LG and COVID-19.